In the last decade, it has become evident that complex mixtures of cyanobacterial bioactive substances, simultaneously present in blooms, often exert adverse effects that are different from those of pure cyanotoxins, and awareness has been raised on the importance of studying complex mixtures and chemical interactions. We aimed to investigate cytotoxic and genotoxic effects of complex extracts from laboratory cultures of cyanobacterial species from different orders (Cylindrospermopsis raciborskii, Aphanizomenon gracile, Microcystis aeruginosa, M. viridis, M. ichtyoblabe, Planktothrix agardhii, Limnothrix redekei) and algae (Desmodesmus quadricauda), and examine possible relationships between the observed effects and toxin and retinoic acid (RA) content in the extracts. The cytotoxic and genotoxic effects of the extracts were studied in the human hepatocellular carcinoma HepG2 cell line, using the MTT assay, and the comet and cytokinesis-block micronucleus (cytome) assays, respectively. Liquid chromatography electrospray ionization mass spectrometry (LC/ESI-MS) was used to detect toxins (microcystins (MC-LR, MC-RR, MC-YR) and cylindrospermopsin) and RAs (ATRA and 9cis-RA) in the extracts. Six out of eight extracts were cytotoxic (0.04-2 mgDM/mL), and five induced DNA strand breaks at non-cytotoxic concentrations (0.2-2 mgDM/mL). The extracts with genotoxic activity also had the highest content of RAs and there was a linear association between RA content and genotoxicity, indicating their possible involvement; however further research is needed to identify and confirm the compounds involved and to elucidate possible genotoxic effects of RAs.

Department of Genetic Toxicology and Cancer Biology National Institute of Biology Večna pot 111 1000 Ljubljana Slovenia

RECETOX Faculty of Science Masaryk University Kamenice 5 62500 Brno Czech Republic

Zobrazit více v PubMed

Buratti F.M., Manganelli M., Vichi S., Stefanelli M., Scardala S., Testai E., Funari E. Cyanotoxins: Producing organisms, occurrence, toxicity, mechanism of action and human health toxicological risk evaluation. Arch. Toxicol. 2017;91:1049–1130. doi: 10.1007/s00204-016-1913-6. PubMed DOI

Huisman J., Codd G.A., Paerl H.W., Ibelings B.W., Verspagen J.M.H., Visser P.M. Cyanobacterial blooms. Nat. Rev. Microbiol. 2018;16:471–483. doi: 10.1038/s41579-018-0040-1. PubMed DOI

Scholz S.N., Esterhuizen-Londt M., Pflugmacher S. Rise of toxic cyanobacterial blooms in temperate freshwater lakes: Causes, correlations and possible countermeasures. Toxicol. Environ. Chem. 2017;99:543–577. doi: 10.1080/02772248.2016.1269332. DOI

Codd G.A., Meriluoto J., Metcalf J.S. Introduction: Cyanobacteria, Cyanotoxins, Their Human Impact, and Risk Management. In: Meriluoto J., Spoof L., Codd G.A., editors. Handbook of Cyanobacterial Monitoring and Cyanotoxin Analysis. John Wiley & Sons, Ltd.; Chichester, UK: 2017. pp. 3–8.

Lee J., Rai P.K., Jeon Y.J., Kim K.-H., Kwon E.E. The role of algae and cyanobacteria in the production and release of odorants in water. Environ. Pollut. 2017;227:252–262. doi: 10.1016/j.envpol.2017.04.058. PubMed DOI

Svirčev Z., Drobac D., Tokodi N., Mijović B., Codd G.A., Meriluoto J. Toxicology of microcystins with reference to cases of human intoxications and epidemiological investigations of exposures to cyanobacteria and cyanotoxins. Arch. Toxicol. 2017;91:621–650. doi: 10.1007/s00204-016-1921-6. PubMed DOI

Chorus I. Introduction: Cyanotoxins—Research for Environmental Safety and Human Health. In: Chorus I., editor. Cyanotoxins: Occurrence, Causes, Consequences. Springer; Berlin/Heidelberg, Germany: 2001.

Bláhová L., Babica P., Adamovský O., Kohoutek J., Maršálek B., Bláha L. Analyses of cyanobacterial toxins (microcystins, cylindrospermopsin) in the reservoirs of the Czech Republic and evaluation of health risks. Environ. Chem. Lett. 2008;6:223–227. doi: 10.1007/s10311-007-0126-x. DOI

Bláhová L., Babica P., Maršálková E., Maršálek B., Bláha L. Concentrations and Seasonal Trends of Extracellular Microcystins in Freshwaters of the Czech Republic—Results of the National Monitoring Program. CLEAN—Soil Air Water. 2007;35:348–354. doi: 10.1002/clen.200700010. DOI

Žegura B., Štraser A., Filipič M. Genotoxicity and potential carcinogenicity of cyanobacterial toxins—A review. Mutat. Res./Rev. Mutat. Res. 2011;727:16–41. doi: 10.1016/j.mrrev.2011.01.002. PubMed DOI

Svirčev Z., Lalić D., Bojadžija Savić G., Tokodi N., Drobac Backović D., Chen L., Meriluoto J., Codd G.A. Global Geographical and Historical Overview of Cyanotoxin Distribution and Cyanobacterial Poisonings. Volume 93. Springer; Berlin/Heidelberg, Germany: 2019. PubMed

Zegura B. An Overview of the Mechanisms of Microcystin-LR Genotoxicity and Potential Carcinogenicity. Mini Rev. Med. Chem. 2016;16:1042–1062. doi: 10.2174/1389557516666160308141549. PubMed DOI

Bouaïcha N., Miles C.O., Beach D.G., Labidi Z., Djabri A., Benayache N.Y., Nguyen-Quang T. toxins Structural Diversity, Characterization and Toxicology of Microcystins. Toxins. 2019;11:714. doi: 10.3390/toxins11120714. PubMed DOI PMC

IARC . Ingested Nitrate and Nitrite, and Cyanobacterial Peptide Toxins. International Agency for Research on Cancer; Lyon, France: 2010. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 94.

Runnegar M.T., Xie C., Snider B.B., Wallace G.A., Weinreb S.M., Kuhlenkamp J. In Vitro Hepatotoxicity of the Cyanobacterial Alkaloid Cylindrospermopsin and Related Synthetic Analogues. Toxicol. Sci. 2002;67:81–87. doi: 10.1093/toxsci/67.1.81. PubMed DOI

Pichardo S., Cameán A.M., Jos A. In vitro toxicological assessment of cylindrospermopsin: A review. Toxins. 2017;9:402. doi: 10.3390/toxins9120402. PubMed DOI PMC

Hrouzek P., Kapuścik A., Vacek J., Voráčová K., Paichlová J., Kosina P., Voloshko L., Ventura S., Kopecký J. Cytotoxicity evaluation of large cyanobacterial strain set using selected human and murine in vitro cell models. Ecotoxicol. Environ. Saf. 2016;124:177–185. doi: 10.1016/j.ecoenv.2015.10.020. PubMed DOI

Smutná M., Babica P., Jarque S., Hilscherová K., Maršálek B., Haeba M., Bláha L. Acute, chronic and reproductive toxicity of complex cyanobacterial blooms in Daphnia magna and the role of microcystins. Toxicon. 2014;79:11–18. doi: 10.1016/j.toxicon.2013.12.009. PubMed DOI

Sieroslawska A. Assessment of the mutagenic potential of cyanobacterial extracts and pure cyanotoxins. Toxicon. 2013;74:76–82. doi: 10.1016/j.toxicon.2013.07.029. PubMed DOI

Ding W.-X., Shen H.-M., Zhu H.-G., Lee B.-L., Ong C.-N. Genotoxicity of microcystic cyanobacteria extract of a water source in China. Mutat. Res. Toxicol. Environ. Mutagen. 1999;442:69–77. doi: 10.1016/S1383-5718(99)00064-9. PubMed DOI

Bláha L., Babica P., Hilscherová K., Upham B.L. Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts—Indications of novel tumor-promoting cyanotoxins? Toxicon. 2010;55:126–134. doi: 10.1016/j.toxicon.2009.07.009. PubMed DOI PMC

Funari E., Testai E. Human Health Risk Assessment Related to Cyanotoxins Exposure. Crit. Rev. Toxicol. 2008;38:97–125. doi: 10.1080/10408440701749454. PubMed DOI

Jonas A., Scholz S., Fetter E., Sychrova E., Novakova K., Ortmann J., Benisek M., Adamovsky O., Giesy J.P., Hilscherova K. Endocrine, teratogenic and neurotoxic effects of cyanobacteria detected by cellular in vitro and zebrafish embryos assays. Chemosphere. 2015;120:321–327. doi: 10.1016/j.chemosphere.2014.07.074. PubMed DOI

Priebojová J., Hilscherová K., Procházková T., Sychrová E., Smutná M. Intracellular and extracellular retinoid-like activity of widespread cyanobacterial species. Ecotoxicol. Environ. Saf. 2018;150:312–319. doi: 10.1016/j.ecoenv.2017.12.048. PubMed DOI

Javůrek J., Sychrová E., Smutná M., Bittner M., Kohoutek J., Adamovský O., Nováková K., Smetanová S., Hilscherová K. Retinoid compounds associated with water blooms dominated by Microcystis species. Harmful Algae. 2015;47:116–125. doi: 10.1016/j.hal.2015.06.006. DOI

Pipal M., Priebojova J., Koci T., Blahova L., Smutna M., Hilscherova K. Field cyanobacterial blooms producing retinoid compounds cause teratogenicity in zebra fi sh embryos. Chemosphere. 2020;241:125061. doi: 10.1016/j.chemosphere.2019.125061. PubMed DOI

Sehnal L., Procházková T., Smutná M., Kohoutek J., Lepšová-Skácelová O., Hilscherová K. Widespread occurrence of retinoids in water bodies associated with cyanobacterial blooms dominated by diverse species. Water Res. 2019;156:136–147. doi: 10.1016/j.watres.2019.03.009. PubMed DOI

Kaya K., Sano T. Handbook of Cyanobacterial Monitoring and Cyanotoxin Analysis. John Wiley & Sons, Ltd.; Hoboken, NJ, USA: 2017. Cyanobacterial Retinoids; pp. 173–178.

Alakhras R.S., Stephanou G., Demopoulos N.A., Nikolaropoulos S.S. Genotoxicity of all-trans retinoic acid (ATRA) and its steroidal analogue EA-4 in human lymphocytes and mouse cells in vitro. Cancer Lett. 2011;306:15–26. doi: 10.1016/j.canlet.2011.02.010. PubMed DOI

Balaban F., Ates-Alagoz Z., Buyukbingol E., Iscan M. Genotoxicity studies on benzimidazole retinoids. Pharmazie. 2005;60:861–868. PubMed

de Almeida Vasconcelos Fonseca E.M. All-trans and 9-cis retinoic acids, retinol and -carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage. Carcinogenesis. 2005;26:1940–1946. doi: 10.1093/carcin/bgi161. PubMed DOI

Hamid R., Rotshteyn Y., Rabadi L., Parikh R., Bullock P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol. Vitr. 2004;18:703–710. doi: 10.1016/j.tiv.2004.03.012. PubMed DOI

Díez-Quijada L., Hercog K., Štampar M., Filipič M., Cameán A.M., Jos Á., Žegura B. Genotoxic Effects of Cylindrospermopsin, Microcystin-LR and Their Binary Mixture in Human Hepatocellular Carcinoma (HepG2) Cell Line. Toxins. 2020;12:778. doi: 10.3390/toxins12120778. PubMed DOI PMC

Hercog K., Maisanaba S., Filipič M., Jos Á., Cameán A.M., Žegura B. Genotoxic potential of the binary mixture of cyanotoxins microcystin-LR and cylindrospermopsin. Chemosphere. 2017;189:319–329. doi: 10.1016/j.chemosphere.2017.09.075. PubMed DOI

Hercog K., Maisanaba S., Filipič M., Sollner-Dolenc M., Kač L., Žegura B. Genotoxic activity of bisphenol A and its analogues bisphenol S, bisphenol F and bisphenol AF and their mixtures in human hepatocellular carcinoma (HepG2) cells. Sci. Total Environ. 2019;687:267–276. doi: 10.1016/j.scitotenv.2019.05.486. PubMed DOI

Westerink W.M.A., Schoonen W.G.E.J. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. Vitr. 2007;21:1581–1591. doi: 10.1016/j.tiv.2007.05.014. PubMed DOI

Ma M., Pi F., Wang J., Ji J., Sun X. New insights into cytotoxicity induced by microcystin-LR, estradiol, and ractopamine with mathematical models: Individual and combined effects. Chemosphere. 2017;168:223–233. doi: 10.1016/j.chemosphere.2016.10.004. PubMed DOI

Lundqvist J., Pekar H., Oskarsson A. Microcystins activate nuclear factor erythroid 2-related factor 2 (Nrf2) in human liver cells in vitro—Implications for an oxidative stress induction by microcystins. Toxicon. 2017;126:47–50. doi: 10.1016/j.toxicon.2016.12.012. PubMed DOI

Al-Sheddi E.S., Al-Oqail M.M., Saquib Q., Siddiqui M.A., Musarrat J., Al-Khedhairy A.A., Farshori N.N. Novel All Trans-Retinoic Acid Derivatives: Cytotoxicity, Inhibition of Cell Cycle Progression and Induction of Apoptosis in Human Cancer Cell Lines. Molecules. 2015;20:8181–8197. doi: 10.3390/molecules20058181. PubMed DOI PMC

Fang S., Hu C., Xu L., Cui J., Tao L., Gong M., Wang Y., He Y., He T., Bi Y. All-trans-retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating autophagy. Am. J. Transl. Res. 2020;12:6793. PubMed PMC

Um S.-J., Sin H.-S., Han H.-S., Kwon Y.-J., Kim E.-J., Park S.-H., Kim S.-Y., Bae T.-S., Park J.-S., Rho Y.-S. Potent cytotoxic effects of novel retinamide derivatives in ovarian cancer cells. Biol. Pharm. Bull. 2003;26:1412–1417. doi: 10.1248/bpb.26.1412. PubMed DOI

Abramsson-Zetterberg L., Sundh U.B., Mattsson R. Cyanobacterial extracts and microcystin-LR are inactive in the micronucleus assay in vivo and in vitro. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2010;699:5–10. doi: 10.1016/j.mrgentox.2010.04.001. PubMed DOI

Scarlett K.R., Kim S., Lovin L.M., Chatterjee S., Scott J.T., Brooks B.W. Global scanning of cylindrospermopsin: Critical review and analysis of aquatic occurrence, bioaccumulation, toxicity and health hazards. Sci. Total Environ. 2020;738:139807. doi: 10.1016/j.scitotenv.2020.139807. PubMed DOI PMC

Díez-Quijada L., Prieto A.I., Guzmán-Guillén R., Jos A., Cameán A.M. Occurrence and toxicity of microcystin congeners other than MC-LR and MC-RR: A review. Food Chem. Toxicol. 2019;125:106–132. doi: 10.1016/j.fct.2018.12.042. PubMed DOI

Žegura B., Sedmak B., Filipič M. Microcystin-LR induces oxidative DNA damage in human hepatoma cell line HepG2. Toxicon. 2003;41:41–48. doi: 10.1016/S0041-0101(02)00207-6. PubMed DOI

Žegura B., Filipič M. Optimization in Drug Discovery. Humana Press; Totowa, NJ, USA: 2004. Application of In Vitro Comet Assay for Genotoxicity Testing; pp. 301–313.

Palus J., Dziubałtowska E., Stańczyk M., Lewińska D., Mankiewicz-Boczek J., Izydorczyk K., Bonisławska A., Jurczak T., Zalewski M., Wąsowicz W. Biomonitoring Of Cyanobacterial Blooms in Polish Water Reservoir And The Cytotoxicity and Genotoxicity Of Selected Cyanobacterial Extracts. Int. J. Occup. Med. Environ. Health. 2007;20:48–56. doi: 10.2478/v10001-007-0008-2. PubMed DOI

Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Proceedings of the Environmental and Molecular Mutagenesis. Volume 35. John Wiley & Sons, Ltd.; Hoboken, NJ, USA: 2000. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing; pp. 206–221. PubMed

OECD . OECD Guideline for the Testing of Chemicals. OECD; Paris, France: 2016. Test No. 487: In Vitro Mammalian Cell Micronucleus Test.

Štraser A., Filipič M., Žegura B. Genotoxic effects of the cyanobacterial hepatotoxin cylindrospermopsin in the HepG2 cell line. Arch. Toxicol. 2011;85:1617–1626. doi: 10.1007/s00204-011-0716-z. PubMed DOI

Fenech M. The in vitro micronucleus technique. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2000;455:81–95. doi: 10.1016/S0027-5107(00)00065-8. PubMed DOI